SYN - Synthetic Bio up 9% on advancement of co-lead candidate January, 07 2020 12:13 PM Synthetic Biologics Inc. Thinly traded nano cap Synthetic Biologics (SYN +8.7%) is up a 17x surge in volume in reaction to its update on co-lead candidate SYN-004 (ribaxamase).More news on: Synthetic Biologics, Inc., Healthcare stocks news, Stocks on the move, Read more ...